L Goldenthal Isaac, Rosenbaum Marlon S, Lewis Matthew, Sciacca Robert R, Garan Hasan, Biviano Angelo B
Internal Medicine, Division of Cardiology, Columbia University Irving Medical Center, 622 W 168th St, New York, NY 10032, USA.
Int J Cardiol Heart Vasc. 2020 May 26;28:100543. doi: 10.1016/j.ijcha.2020.100543. eCollection 2020 Jun.
Patients with Tetralogy of Fallot (TOF) are at increased risk for sudden cardiac death, often undergo implantable cardioverter defibrillator (ICD) implantation at younger ages, and are at greater risk of experiencing inappropriate shocks. We investigated occurrences of ICD shocks in TOF patients to identify prevalence, characteristics associated with inappropriate shocks, and therapeutic interventions after inappropriate shocks.
Records of patients with repaired TOF and ICD implantation who were followed at Columbia University Irving Medical Center between 1/1/2000 and 5/1/2019 were analyzed.
44 patients with repaired TOF and ICD implantation were reviewed. Mean age at implantation was 39 ± 13 years. Eight (18%) patients received both appropriate and inappropriate shocks, 6 (14%) received only appropriate shocks, and 3 (7%) received only inappropriate shocks. Three patients received inappropriate shocks for sinus tachycardia, 7 for atrial arrhythmias, and 1 for noise artifact. Inappropriately shocked patients had lower beat per minute (bpm) cutoff values for ICD therapy (mean = 162 ± 24 bpm vs. 182 ± 16 bpm, p = 0.007). After inappropriate shocks, 1 patient underwent lead replacement, 1 had the VT cutoff increased, and 6 were treated with medications.
One quarter of TOF patients with ICDs experienced inappropriate shock therapy, the timing of which was most often clustered within the first two years after implant or years later. Lower shock therapy zones were associated with increased risk for inappropriate shocks, and the majority of inappropriate shocks resulted from atrial arrhythmias with rapid ventricular response. Treatments for inappropriate shocks included increasing VT therapy bpm and rhythm and/or rate control medications.
法洛四联症(TOF)患者心脏性猝死风险增加,常较年轻时接受植入式心律转复除颤器(ICD)植入,且发生不适当电击的风险更高。我们调查了TOF患者ICD电击的发生情况,以确定其发生率、与不适当电击相关的特征以及不适当电击后的治疗干预措施。
分析了2000年1月1日至2019年5月1日在哥伦比亚大学欧文医学中心接受随访的TOF修复术后且植入ICD患者的记录。
回顾了44例TOF修复术后且植入ICD的患者。植入时的平均年龄为39±13岁。8例(18%)患者既接受了适当电击也接受了不适当电击,6例(14%)仅接受了适当电击,3例(7%)仅接受了不适当电击。3例患者因窦性心动过速接受了不适当电击,7例因房性心律失常,1例因噪音伪差。接受不适当电击的患者ICD治疗的每分钟心跳(bpm)截止值较低(平均=162±24 bpm对182±16 bpm,p=0.007)。不适当电击后,1例患者进行了导线更换,1例提高了室性心动过速(VT)截止值,6例接受了药物治疗。
四分之一植入ICD的TOF患者经历了不适当的电击治疗,其时间大多集中在植入后的头两年内或数年之后。较低的电击治疗区域与不适当电击风险增加相关,且大多数不适当电击由伴有快速心室反应的房性心律失常引起。不适当电击的治疗方法包括提高VT治疗的bpm以及节律和/或心率控制药物。